Two phase 3 trials of dronedarone, a novel class III antiarrhythmic agent currently in development worldwide, have demonstrated that the drug is safe and effective for the maintenance of normal sinus ...
Abstract and Introduction Evidence for a Proarrhythmic Effect of LV Pacing Evidence For an Antiarrhythmic Effect of CRT Conclusions References There are very few experimental studies that examined ...
WASHINGTON D.C., February 29, 2016 - If you suffer from atrial fibrillation (AF) -- a condition where disorganized electrical signals cause the heart's upper chambers to contract quickly and ...
HUYABIO Validates Protective Mechanism for Antiarrhythmic Drug HBI-3000 in AF Patients, Paving the Way for a New Era in Atrial Fibrillation Treatment PR Newswire SAN DIEGO, Nov. 14, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results